YER130C Antibody

What is YER130C and what is its significance in Saccharomyces cerevisiae research?

YER130C is a specific protein found in Saccharomyces cerevisiae (strain ATCC 204508/S288c), commonly known as baker's yeast. The antibody targeting this protein allows researchers to study its expression, localization, and function. When designing experiments with YER130C antibody, researchers should consider the protein's native expression levels, subcellular localization, and potential post-translational modifications. Methodologically, researchers should first validate the antibody's specificity against yeast lysates using Western blot with appropriate positive and negative controls to establish baseline detection parameters before proceeding to more complex applications .

How are antibodies against yeast proteins like YER130C generated and validated?

Antibodies against yeast proteins like YER130C are typically generated through hybridoma technology. This process begins with immunizing animals (commonly mice or rabbits) with purified YER130C protein or synthetic peptides corresponding to unique epitopes. The B cells that produce antibodies against the target are then fused with immortalized myeloma cells to create hybridomas that can produce unlimited amounts of monoclonal antibodies with consistent specificity .

Validation requires multiple approaches:

• Western blotting with wild-type and YER130C knockout yeast strains

• Immunoprecipitation followed by mass spectrometry

• Immunofluorescence comparing localization patterns with GFP-tagged versions

• Flow cytometry to assess binding to intact yeast cells

Cross-reactivity testing against related yeast species and closely related proteins is essential to confirm specificity. Researchers should examine binding affinity measurements, which for high-quality antibodies typically reach 10^-9 to 10^-11 M ranges, similar to well-characterized therapeutic antibodies like porustobart .

What experimental considerations are critical when using flow cytometry with YER130C antibody?

When designing flow cytometry experiments with YER130C antibody, several methodological considerations are essential:

• Cell wall permeabilization: Yeast cells require special permeabilization protocols (typically using zymolyase or lyticase) to allow antibody access to intracellular targets

• Fluorophore selection: Choose fluorophores with minimal spectral overlap with yeast autofluorescence

• Binding validation: Validate antibody binding by comparing fluorescence signals from wild-type and YER130C mutant strains

For optimal sorting results, fluorescence-activated cell sorting (FACS) parameters should be established by:

• Titrating antibody concentrations (typically 1-10 μg/mL)

• Optimizing incubation conditions (time and temperature)

• Establishing appropriate gating strategies based on controls

This approach allows for isolation of cell populations with varying levels of YER130C expression, enabling subsequent molecular and functional analyses .

How should researchers design experiments to validate YER130C antibody specificity?

Rigorous validation of YER130C antibody specificity requires a multi-faceted approach:

• Genetic controls: Compare antibody reactivity between wild-type yeast and YER130C deletion strains

• Epitope competition: Pre-incubate antibody with purified antigen or immunizing peptide before detection

• Cross-reactivity assessment: Test against related yeast proteins and species

• Multiple detection methods: Validate using Western blot, immunoprecipitation, and immunofluorescence

For Western blot validation, researchers should:

• Run multiple concentrations of yeast lysates

• Include positive controls (purified YER130C protein)

• Include negative controls (lysates from YER130C knockout strains)

• Test multiple antibody dilutions to determine optimal signal-to-noise ratio

This systematic approach ensures that observed signals genuinely represent YER130C rather than non-specific binding or cross-reactivity with related proteins .

What are the optimal immunoprecipitation protocols for YER130C antibody?

Optimized immunoprecipitation (IP) protocols for YER130C antibody should address the unique challenges of yeast cell experiments:

• Lysis buffer optimization:

  • 50 mM Tris-HCl (pH 7.5)

  • 150 mM NaCl

  • 0.1% NP-40

  • 1 mM EDTA

  • Protease inhibitor cocktail

  • 1 mM PMSF

• Cell disruption method:

  • Glass bead lysis for 5-6 cycles (30 seconds on/30 seconds off) at 4°C

  • Alternatively, cryogenic grinding in liquid nitrogen

• Antibody coupling:

  • Direct coupling to protein A/G beads (2-5 μg antibody per 25 μL bead slurry)

  • Cross-linking with dimethyl pimelimidate (DMP) to prevent antibody co-elution

• IP conditions:

  • Incubate lysate with antibody-coupled beads for 2-4 hours at 4°C

  • Wash 4-5 times with lysis buffer

  • Elute with either low pH buffer or SDS sample buffer

This methodology ensures efficient capture of YER130C protein while minimizing non-specific binding, which is particularly important when studying protein-protein interactions in yeast systems .

How can researchers optimize immunofluorescence protocols for YER130C localization studies?

Optimizing immunofluorescence protocols for YER130C requires addressing the challenges of yeast cell wall permeabilization while preserving cellular architecture:

• Fixation and permeabilization:

  • Fix cells with 4% formaldehyde for 30 minutes

  • Digest cell wall with zymolyase (100 μg/mL) for 20-30 minutes at 30°C

  • Permeabilize with 0.1% Triton X-100 for 5 minutes

• Blocking and antibody incubation:

  • Block with 2% BSA in PBS for 1 hour

  • Incubate with YER130C antibody (1:100-1:500 dilution) overnight at 4°C

  • Wash 3 times with PBS-T (PBS + 0.1% Tween-20)

  • Incubate with fluorophore-conjugated secondary antibody for 1 hour at room temperature

• Mounting and imaging considerations:

  • Use anti-fade mounting medium with DAPI for nuclear counterstaining

  • Capture Z-stack images (0.2-0.3 μm intervals) for 3D reconstruction

  • Include co-localization markers for subcellular compartments

• Controls and validation:

  • YER130C deletion strain (negative control)

  • YER130C-GFP fusion strain (positive control)

  • Primary antibody omission control

This comprehensive approach allows accurate determination of YER130C subcellular localization while minimizing artifacts commonly encountered in yeast immunofluorescence studies .

What statistical approaches should be used when analyzing YER130C antibody binding data?

When analyzing YER130C antibody binding data, robust statistical approaches must be employed:

• Binding affinity determination:

  • Use non-linear regression for Scatchard plot analysis

  • Calculate KD values using one-site or two-site binding models

  • Employ statistical tests (F-test) to determine the best-fitting model

• Western blot quantification:

  • Use densitometry with multiple technical replicates (n≥3)

  • Apply normalization to loading controls (e.g., PGK1, TDH3)

  • Employ one-way ANOVA with post-hoc tests for comparing multiple conditions

• Flow cytometry data analysis:

  • Calculate median fluorescence intensity (MFI) rather than mean values

  • Apply appropriate transformations (biexponential) for comparing populations

  • Use Kolmogorov-Smirnov test for comparing distribution shifts

• Immunofluorescence quantification:

  • Perform Pearson or Manders correlation coefficients for co-localization

  • Use Ripley's K function for spatial distribution analysis

  • Apply bootstrapping approaches for confidence interval determination

These statistical methods ensure rigorous interpretation of YER130C antibody data while accounting for biological and technical variability .

How should researchers interpret contradictory results from YER130C antibody experiments?

When faced with contradictory results in YER130C antibody experiments, researchers should implement a systematic troubleshooting approach:

• Technical validation:

  • Repeat experiments with fresh reagents and independently prepared samples

  • Test alternative antibody lots or clones against the same target

  • Vary experimental conditions (buffer compositions, incubation times)

• Biological context assessment:

  • Evaluate cell growth phase effects on YER130C expression

  • Test multiple yeast strains and growth conditions

  • Consider post-translational modifications that might affect epitope recognition

• Complementary methodology:

  • Compare antibody-based results with orthogonal approaches (GFP tagging, mass spectrometry)

  • Validate findings using genetic manipulations (knockout, overexpression)

  • Perform epitope mapping to identify potential issues with antibody recognition sites

• Data integration framework:

  • Create a decision matrix weighing evidence from multiple experimental approaches

  • Identify patterns in contradictory data that might reveal biological complexity

  • Consider developing mathematical models to reconcile apparently conflicting observations

This structured approach helps distinguish genuine biological phenomena from technical artifacts when interpreting complex datasets generated with YER130C antibody .

What are the key considerations when comparing YER130C expression across different experimental conditions?

When comparing YER130C expression across various experimental conditions, researchers should consider several methodological aspects:

• Sample normalization strategies:

  Normalization Method	Advantages	Limitations
  Total protein loading	Simple, widely applicable	May vary with treatment conditions
  Housekeeping proteins	Established methodology	Can vary under stress conditions
  Spike-in controls	High accuracy	Requires additional reagents
  Global normalization	Accounts for proteome-wide changes	Requires advanced instrumentation

• Technical considerations:

  • Use identical sample preparation protocols across conditions

  • Process all samples in parallel to minimize batch effects

  • Include gradient-loaded standard curves for quantitative comparisons

  • Apply appropriate transformations based on data distribution

• Biological variability management:

  • Use sufficient biological replicates (minimum n=3, preferably n≥5)

  • Account for cell cycle effects on YER130C expression

  • Consider strain background influences on expression patterns

  • Evaluate metabolic state effects on protein stability and turnover

• Data presentation:

  • Report raw data alongside normalized values

  • Include appropriate statistical measures (confidence intervals, p-values)

  • Visualize data using box plots or violin plots rather than simple bar graphs

  • Provide access to complete datasets for independent validation

These approaches ensure robust and reproducible comparisons of YER130C expression across diverse experimental conditions .

How can researchers use YER130C antibody to study protein-protein interactions?

Researchers can employ several advanced methodologies with YER130C antibody to study protein-protein interactions:

• Co-immunoprecipitation (Co-IP) optimization:

  • Use gentle lysis conditions to preserve native complexes

  • Cross-link interacting proteins (formaldehyde or DSP) for transient interactions

  • Optimize salt and detergent concentrations to balance specificity and yield

  • Implement two-step purification (tandem affinity purification) for enhanced specificity

• Proximity-based labeling approaches:

  • Combine YER130C antibody with BioID or APEX2 proximity labeling

  • Use antibody to validate proximity labeling results

  • Develop split-BioID systems with YER130C-fusion proteins

  • Combine with mass spectrometry for systematic interaction mapping

• In situ interaction analysis:

  • Apply proximity ligation assay (PLA) with YER130C antibody

  • Optimize signal amplification parameters for yeast cell applications

  • Use FRET or FLIM-FRET with antibody-conjugated fluorophores

  • Develop super-resolution microscopy protocols compatible with YER130C antibody

• Dynamic interaction monitoring:

  • Implement real-time co-IP approaches for temporal interaction studies

  • Develop fluorescence correlation spectroscopy protocols

  • Apply single-molecule tracking with antibody fragments

  • Use microfluidic approaches for rapid condition changes

These methodologies enable comprehensive characterization of YER130C protein interaction networks across different cellular conditions and states .

What approaches enable studying YER130C post-translational modifications using antibody-based techniques?

To study post-translational modifications (PTMs) of YER130C using antibody-based techniques, researchers should consider these specialized approaches:

• PTM-specific antibody development and validation:

  • Generate phospho-specific, ubiquitin-specific, or other PTM-specific antibodies

  • Validate specificity using dephosphorylation assays or deubiquitination treatments

  • Confirm specificity with mutagenesis of predicted modification sites

  • Develop quantitative assays for modification stoichiometry determination

• Enrichment strategies for modified forms:

  • Implement phosphopeptide enrichment (TiO2, IMAC) prior to antibody-based detection

  • Use ubiquitin remnant motif antibodies for ubiquitination site mapping

  • Apply sequential immunoprecipitation strategies for multiply-modified forms

  • Develop fractionation protocols optimized for modified YER130C variants

• Temporal dynamics analysis:

  • Design time-course experiments with synchronized yeast cultures

  • Implement rapid lysis techniques to preserve labile modifications

  • Develop phosphatase/deubiquitinase inhibitor cocktails optimized for yeast

  • Combine with targeted mass spectrometry for absolute quantification

• Functional correlation approaches:

  • Correlate modification patterns with YER130C localization changes

  • Assess modification-dependent protein-protein interactions

  • Develop activity assays to correlate modifications with functional states

  • Implement genetic approaches to prevent or mimic modifications

These specialized techniques allow researchers to dissect the complex landscape of YER130C post-translational modifications and their functional consequences .

How can YER130C antibody be used in evolutionary studies across related yeast species?

Using YER130C antibody for evolutionary studies across yeast species requires careful methodological considerations:

• Cross-reactivity assessment and optimization:

  • Test antibody recognition against predicted homologs in related species

  • Identify conserved epitopes through sequence alignment and structural prediction

  • Optimize antibody concentrations for each species individually

  • Develop species-specific detection protocols based on epitope conservation

• Comparative expression analysis:

  • Standardize lysate preparation across diverse yeast species

  • Develop calibration curves for each species to enable quantitative comparisons

  • Account for codon usage bias effects on protein abundance

  • Normalize against multiple conserved reference proteins

• Functional conservation assessment:

  • Compare subcellular localization patterns across species

  • Analyze protein-protein interaction networks in multiple yeasts

  • Assess condition-dependent expression changes in diverse species

  • Correlate expression patterns with species-specific phenotypes

• Experimental evolution approaches:

  • Monitor YER130C expression changes during laboratory evolution

  • Assess antibody binding to evolving populations over time

  • Develop protocols for tracking expression in hybrid or chimeric yeast strains

  • Combine with genomic analyses to correlate sequence and expression evolution

This comprehensive methodology enables researchers to leverage YER130C antibody for understanding protein evolution across fungal phylogeny .

What are common technical challenges with YER130C antibody experiments and their solutions?

Researchers commonly encounter several technical challenges when working with YER130C antibody:

• High background signal in Western blots:

  • Increase blocking time (overnight at 4°C with 5% BSA)

  • Try alternative blocking agents (milk vs. BSA vs. casein)

  • Increase wash duration and volume (5× 10-minute washes)

  • Optimize antibody dilution through systematic titration

  • Pre-adsorb antibody with yeast lysate from YER130C knockout strain

• Poor signal in immunofluorescence:

  • Optimize cell wall digestion (test multiple zymolyase concentrations)

  • Try alternative fixation methods (methanol vs. formaldehyde)

  • Implement antigen retrieval protocols (mild heat treatment)

  • Use signal amplification systems (tyramide signal amplification)

  • Extend primary antibody incubation time (up to 48 hours at 4°C)

• Inconsistent immunoprecipitation results:

  • Test different lysis buffers varying in ionic strength and detergent content

  • Pre-clear lysates with protein A/G beads before immunoprecipitation

  • Cross-link antibody to beads to prevent co-elution

  • Include competitors for non-specific interactions (0.1-0.5% BSA)

  • Implement stringent wash protocols with increasing salt concentrations

• Batch-to-batch variability:

  • Establish internal reference standards for each new antibody lot

  • Create standard curves with purified antigen for quantitative normalization

  • Maintain detailed records of antibody performance across experiments

  • Consider monoclonal alternatives if polyclonal variability is problematic

These troubleshooting approaches systematically address the most common technical challenges encountered when working with YER130C antibody in various experimental contexts .

How can researchers ensure reproducibility in studies using YER130C antibody?

Ensuring reproducibility in YER130C antibody-based research requires implementing several methodological best practices:

• Antibody validation and documentation:

  • Document complete antibody information (source, lot, clone)

  • Perform independent validation for each new lot received

  • Maintain detailed protocols for all validation experiments

  • Share validation data through open repositories or supplementary materials

• Experimental design considerations:

  • Implement randomization and blinding where appropriate

  • Calculate appropriate sample sizes through power analysis

  • Include all relevant controls in each experimental run

  • Standardize protocols across experimental batches

• Data processing standardization:

  • Document all image acquisition parameters

  • Use consistent analysis workflows for all datasets

  • Implement automated analysis pipelines to reduce subjective bias

  • Retain raw data alongside processed results

• Reporting and transparency:

  Reproducibility Element	Implementation Strategy
  Reagent documentation	Report catalog numbers, lot numbers, validation data
  Protocol sharing	Provide detailed, step-by-step protocols in methods
  Data availability	Deposit raw data in appropriate repositories
  Analysis transparency	Share analysis code and parameters
  Limitation acknowledgment	Discuss known limitations and failed approaches

These practices ensure that research conducted with YER130C antibody can be reliably reproduced across different laboratories and experimental conditions .

What control experiments are essential when conducting YER130C antibody studies?

Essential control experiments for YER130C antibody studies include:

• Genetic controls:

  • YER130C knockout strain (negative control)

  • YER130C overexpression strain (positive control)

  • Tagged YER130C strain (epitope tag validation)

  • Rescue experiments in knockout backgrounds

• Antibody specificity controls:

  • Primary antibody omission

  • Isotype-matched irrelevant antibody

  • Antibody pre-absorption with immunizing peptide

  • Competitive binding with purified antigen

• Technical validation controls:

  • Serial dilution series for linearity assessment

  • Loading controls for normalization

  • Inter-assay calibration standards

  • Process controls (samples processed identically except for one variable)

• Application-specific controls:

  • For immunoprecipitation: IgG control, input sample

  • For immunofluorescence: Autofluorescence control, secondary-only control

  • For Western blotting: Molecular weight markers, cross-reactivity panel

  • For flow cytometry: Unstained cells, single-color controls, FMO controls